Combining methionine-PET and MRI fluid-attenuated inversion-recovery mismatch to determine glioma molecular subtype.
Kazufumi OhmuraNobutoshi KumagaiMorio KumagaiYuka IkegameJun ShinodaHirohito YanoYoshihiro MuragakiToru IwamaPublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2023)
The combination of the T2-FLAIR mismatch sign and MET-PET may provide improved diagnostic utility in differentiating gliomas according to molecular subtype, particularly in determining IDH mutation status.